Emergent, HHS disclose $250M updated contract that includes anthrax and smallpox vaccines

Emer­gent BioSo­lu­tions scored more than $250 mil­lion in gov­ern­ment con­tract mod­i­fi­ca­tions for four med­ical coun­ter­mea­sures, in­clud­ing an­thrax, small­pox and bot­u­lism vac­cines.

As part of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Why Buy Cannabis Stocks

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

Read More »